Stage I Thyroid Gland Papillary Carcinoma
2 clinical trials · Condition
◉ Watch Stage I Thyroid Gland Papillary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer (NCT01811212) | National Cancer Institute (NCI) | 2013-05-08 |
| Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine (NCT00559949) | National Cancer Institute (NCI) | 2007-12-01 |
Track Stage I Thyroid Gland Papillary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.